Development of a method to assess EAAT1 transcription levels in Alzheimer's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Ereignis
-
Veröffentlichung
- (wo)
-
Potsdam
- (wer)
-
Universität Potsdam
- (wann)
-
2008
- Urheber
-
Köchert, Karl
- URN
-
urn:nbn:de:kobv:517-opus-15965
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Köchert, Karl
- Universität Potsdam
Entstanden
- 2008
Ähnliche Objekte (12)
Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer’s Disease
Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Integrated method to assess resource efficiency – ESSENZ
Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
An intelligent Alzheimer’s disease diagnosis method using unsupervised feature learning
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
A Quick Method to Assess Airway Distensibility in Mice
Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer’s Disease
Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Integrated method to assess resource efficiency – ESSENZ
Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
An intelligent Alzheimer’s disease diagnosis method using unsupervised feature learning
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
A Quick Method to Assess Airway Distensibility in Mice
Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer’s Disease
Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Integrated method to assess resource efficiency – ESSENZ
Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
An intelligent Alzheimer’s disease diagnosis method using unsupervised feature learning
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Melatonin levels in the Alzheimer’s disease continuum: a systematic review